How Much Does Treatment in China Cost? A Guide for International Patients

For many international patients, cost is one of the biggest reasons to consider medical tourism in China — but "how much will it actually cost?" is rarely answered clearly. This guide sets out realistic figures and what shapes them.

The headline: 60–80% less than the United States

For most complex procedures, treatment at China's leading hospitals costs 60–80% less than in the United States, and materially less than in Western Europe — without cutting corners on internationally calibrated standards. The savings come from lower structural costs, not lower quality: the same class of equipment, internationally trained specialists, and some of the highest-volume programs in the world.

Real examples

CAR-T cell therapy. A full course of CAR-T for blood cancers is priced in China roughly between $100,000 and $180,000, compared with $375,000–$475,000 in the United States for the commercially available products. China has approved seven CAR-T therapies — second only to the US — so there is genuine choice, not a single option.

Proton therapy. A full course of proton therapy at a leading Chinese center is typically priced around RMB 210,000–300,000 (roughly $30,000–$45,000) — a fraction of typical Western self-pay costs, using the same internationally calibrated equipment platforms.

Access to global medicines. Through the Hainan Boao Lecheng special-access zone, FDA/EMA-approved drugs not yet registered on the mainland can be cleared for a specific patient's use in 3–7 days — including rare-disease and pediatric agents.

What drives your final price

Every case is different. The main factors are:

• The treatment itself — surgery, cell therapy, radiation, and drug regimens carry very different costs.
• Length of stay — inpatient days, ICU time, and rehabilitation.
• Medications and devices — especially any imported through special-access channels.
• Hospital tier — public National Medical Centers versus JCI-accredited private hospitals.

How to get a real number

Published ranges are a starting point, not a quote. NF MediPath provides a transparent, itemized estimate as part of your case review — after Chinese specialists have reviewed your diagnosis and records, so the number reflects your actual treatment plan, not an average.

Request a confidential case review →

Sources: CGTLive — CAR-T pricing · People's Daily — Boao Lecheng special access